Secondary Healthcare System
Tertiary Healthcare System
Integrated Healthcare System
Nursing Clinical Information System
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 1, 2026

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
Maksim R Kaimonov1, Tatiana V Safronova1,2
1Department of Materials Science, Lomonosov Moscow State University, Leninskie Gory 1, Building 73, 119991 Moscow, Russia.
This review explores the use of materials in the Na2O-CaO-SiO2-P2O5 system for medical applications. Calcium phosphate materials like hydroxyapatite and tricalcium phosphate are commonly used but have limitations in mechanical strength. Bioglass 45S5 is a known material in this system that offers bioactivity but lacks durability. The authors suggest that combining these materials into composites may improve performance. The review highlights the role of silicon in these composites and suggests that composite ceramics could be a promising solution for medical use. The findings indicate that further research into composite materials may lead to better outcomes.
Area of Science:
Background:
For over half a century, scientists have explored calcium phosphate and silicon dioxide-based materials due to their compatibility with biological systems. Hydroxyapatite and tricalcium phosphate are well-known calcium phosphate compounds used in medical fields. Bioglass 45S5, a sodium-calcium-silicon-phosphorus system, has also drawn attention for its unique properties. Despite their widespread use, each material has limitations that restrict broader applications. Researchers have noted that these limitations often stem from mechanical or chemical constraints. The need for improved performance has led to investigations into composite materials. Combinations of calcium phosphate and silicon-based compounds may address these issues. This review examines the role of silicon and its compounds in medical materials.
Purpose Of The Study:
This study aims to evaluate the potential of composites derived from calcium phosphate and silicon dioxide systems for medical use. The goal is to understand how combining these materials can overcome individual limitations. The focus is on the Na2O-CaO-SiO2-P2O5 system, particularly Bioglass 45S5. The authors seek to outline the properties of each material and their constraints. They also explore how composites might enhance performance in medical applications. The review considers the role of silicon in these composites. The authors aim to provide a synthesis of current knowledge. By highlighting composite approaches, they aim to suggest new directions for material development.
Main Methods:
The authors conducted a literature review of calcium phosphate and silicon dioxide materials in the Na2O-CaO-SiO2-P2O5 system. They analyzed the properties and limitations of each material separately. The review included studies on hydroxyapatite, tricalcium phosphate, and Bioglass 45S5. The authors examined how these materials perform in medical applications. They also considered the potential of combining these materials into composites. The synthesis of composite ceramics was discussed as an alternative approach. The authors evaluated the role of silicon in these composites. The review approach focused on identifying gaps and opportunities for improvement.
Main Results:
The review highlights that hydroxyapatite and tricalcium phosphate have limited mechanical strength. Bioglass 45S5 offers better bioactivity but lacks mechanical durability. Composites of calcium phosphate and silicon-based materials may enhance performance. The authors suggest that these composites can improve both mechanical and biological properties. The study demonstrates that combining materials can overcome individual limitations. The Na2O-CaO-SiO2-P2O5 system allows for various composite structures. The review shows that silicon compounds play a key role in these composites. The findings suggest that composite ceramics may be a promising direction for medical materials.
Conclusions:
The authors propose that composites based on calcium phosphate and silicon dioxide materials may offer improved performance. They suggest that combining these materials can address individual limitations. The review concludes that the Na2O-CaO-SiO2-P2O5 system has potential for medical applications. The authors recommend further research into composite ceramics. They emphasize the role of silicon in enhancing bioactivity and mechanical strength. The synthesis of composite materials may lead to better medical outcomes. The authors suggest that alternative fabrication methods should be explored. The findings indicate that composites may be a viable solution for current material limitations.
The authors suggest that composites may enhance both mechanical and biological properties.
Bioglass 45S5 is a known material in this system that offers bioactivity but lacks mechanical durability.
Silicon compounds may improve bioactivity and mechanical strength in composite ceramics.
These materials have limited mechanical strength and may not perform well in all medical applications.
This system allows for the development of composite ceramics with improved performance for medical use.
The authors suggest that composites based on calcium phosphate and silicon dioxide may address these limitations.